Biodesix, Inc.
BDSX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $57 | $41 | $92 | $224 |
| - Cash | $17 | $21 | $18 | $26 |
| + Debt | $73 | $72 | $62 | $62 |
| Enterprise Value | $113 | $93 | $136 | $260 |
| Revenue | $22 | $20 | $18 | $20 |
| % Growth | 8.7% | 11.5% | -12.1% | – |
| Gross Profit | $18 | $16 | $14 | $16 |
| % Margin | 81.1% | 79.9% | 79.4% | 78.7% |
| EBITDA | -$5 | -$8 | -$8 | -$5 |
| % Margin | -24% | -40.8% | -44.6% | -25% |
| Net Income | -$9 | -$11 | -$11 | -$8 |
| % Margin | -40% | -57.3% | -61.8% | -40.4% |
| EPS Diluted | -1.16 | -1.6 | -1.6 | -1.2 |
| % Growth | 27.5% | 0% | -33.3% | – |
| Operating Cash Flow | -$9 | -$7 | -$9 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$9 | -$7 | -$9 | -$5 |